APA: With digital mental health going mainstream, will/ should psychologists be able to “prescribe” interventions?

By SharpBrains | January 14, 2022

Men­tal health, meet ven­ture cap­i­tal (APA): Until recent­ly, men­tal health was a rel­a­tive blip on the radar of ven­ture cap­i­tal­ists. But over the past few years, and par­tic­u­lar­ly since the onset of the COVID-19 pan­dem­ic, pri­vate investors have made a dra­mat­ic run for this space, pour­ing $3.1 bil­lion into men­tal health ven­tures by the third…

Read More

Survey of 2500 families finds what ADHD treatments seem to work/ not work as applied in the real world

By Dr. David Rabiner | December 17, 2020

While care­ful­ly con­trolled clin­i­cal tri­als are essen­tial for estab­lish­ing sci­en­tif­ic sup­port for dif­fer­ent ADHD treat­ments, it is also impor­tant to exam­ine how par­ents feel about the treat­ments they actu­al­ly select for their child. How par­ents feel about ADHD treat­ments they have tried for their child pro­vides an impor­tant com­ple­ment to pub­lished clin­i­cal tri­als data, and can…

Read More

Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine

By SharpBrains | December 4, 2020

Click Ther­a­peu­tics Secures $30M in Growth Cap­i­tal from K2 HealthVen­tures to Expand Oper­a­tions (press release): Click Ther­a­peu­tics, Inc. (“Click”), a leader in Dig­i­tal Ther­a­peu­tics™ solu­tions as pre­scrip­tion med­ical treat­ments, today announced $30 mil­lion in debt financ­ing from K2 HealthVen­tures (K2HV), a health­­care-focused spe­cial­ty finance com­pa­ny, to accel­er­ate com­mer­cial­iza­tion of its lead­ing smok­ing ces­sa­tion solu­tion, Clickotine™,…

Read More

The latest on Brain Health and Resilience, plus a few fun Brain Teasers

By SharpBrains | November 30, 2020

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing fas­ci­nat­ing neu­ro­science find­ings and tips, com­bined with fun brain teasers. #1. To cel­e­brate this quite-chal­leng­ing Thanks­giv­ing, here are five fun brain teasers that read­ers have enjoyed the most this year so far. It is always good to learn more about (and appre­ci­ate) that most pre­cious resource…

Read More

Think twice before taking Aderall for cognitive enhancement: It may actually impair working memory and other cognitive abilities

By SharpBrains | July 23, 2018

___ ADHD drugs do not improve cog­ni­tion in healthy col­lege stu­dents (Sci­enceDai­ly): “Con­trary to pop­u­lar belief across col­lege cam­pus­es, atten­tion deficit hyper­ac­tiv­i­ty dis­or­der (ADHD) med­ica­tions may fail to improve cog­ni­tion in healthy stu­dents and actu­al­ly can impair func­tion­ing, accord­ing to a study by researchers at the Uni­ver­si­ty of Rhode Island and Brown University.

Read More